Maciocia, N;
Spencer, D;
Maciocia, P;
Childerhouse, A;
O’Reilly, M;
Payne, E;
Roddie, C;
(2024)
Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report.
Frontiers in Hematology
, 3
10.3389/frhem.2024.1435584.
(In press).
Preview |
Text
frhem-1-1435584.pdf - Published Version Download (770kB) | Preview |
Abstract
Cytopenia is a common side effect after chimeric antigen receptor T cell (CAR-T) therapy but is unusual at late timepoints when it is most commonly due to bone marrow (BM) failure, myelodysplasia (MDS) or other secondary malignancies. In this case report, we describe a patient who developed severe aplastic anaemia 18 months after CD19 CAR-T therapy, and shortly after COVID-19 vaccination. This is the first description of severe aplastic anaemia triggered by COVID-19 vaccination as a cause of post-CAR-T cytopenia. The patient described was treated with a combination of eltrombopag and ciclosporin due to frailty and had a rapid and complete clinical response to this therapy, providing an effective option for the treatment of immune-related cytopenia post-CAR-T in an increasingly elderly and frail population.
Type: | Article |
---|---|
Title: | Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.3389/frhem.2024.1435584 |
Publisher version: | https://doi.org/10.3389/frhem.2024.1435584 |
Language: | English |
Additional information: | © 2024 Maciocia, Spencer, Maciocia, Childerhouse, O’Reilly, Payne and Roddie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
Keywords: | Case report, COVID-19, CAR-T cell, aplastic anaemia, eltrombopag |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10206060 |




Archive Staff Only
![]() |
View Item |